MedTrace Logo

Project Legacy Impact Evaluation Study

NCT03366636 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 571

Last updated 2024-01-03

No results posted yet for this study

Summary

This study will design and rigorously evaluate the efficacy of Project Legacy, a five week positive youth development intervention to decrease sexual risk for unintended pregnancies and STIs among youth experiencing homelessness or at risk of homelessness aged 14-19. This randomized control trial will compare Project Legacy to a usual services control.

Conditions

  • Pregnancy Prevention
  • Sexual Behavior
  • Contraception Behavior
  • Sexually Transmitted Diseases

Interventions

BEHAVIORAL

Project Legacy

Project Legacy - Project Legacy is a 5-week, twice a week, 10 sessions small group intervention that encourages homeless and at-risk of homeless youth ages 14-19 to imagine a positive future and discuss how current risk behaviors can be a barrier to a successful adulthood. The program includes thinking about the future, the importance of positive social supports, short and long-term goal planning, and decision making. The program also includes life skills building, addressing past and current risk behaviors, linking to resources and navigating service systems, information on contraception and condoms, a healthy life plan and self-sufficiency. The 5 content core elements are the following: * 1\. Thinking about the future * 2\. Present actions to achieve future success * 3\. Safeguarding one's future * 4\. Creating a Healthy Life Plan * 5\. Navigating service systems

Sponsors & Collaborators

Principal Investigators

  • Leslie F Clark, PhD, MPH · University of Southern California

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
14 Years
Max Age
19 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-10-30
Primary Completion
2021-03-30
Completion
2021-03-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03366636 on ClinicalTrials.gov